Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating l-arginine production

참고문헌 (54)

1. Younossi, Z., "Global burden of NAFLD and NASH : trends, predictions, risk factors and prevention", Nat. Rev. Gastroenterol. Hepatol, 15, pp.11~20 (2018)
2. Arab, J. P., "Recent insights into the pathogenesis of nonalcoholic fatty liver disease", Annu. Rev. Pathol, 13, pp.321~350 (2018)
3. Chalasani, N., "The diagnosis and management of non-alcoholic fatty liver disease : Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association", Hepatology, 55, pp.2005~2023 (2012)
4. Lindenmeyer, C. C, "The natural history of nonalcoholic fatty liver disease—an evolving view", Clin. Liver Dis, 22, pp.11~21 (2018)
5. Rinella, M. E, "Management of NAFLD: a stage-based approach", Nat. Rev. Gastroenterol. Hepatol, 13, pp.196~205 (2016)
6. European Association for the Study of the Liver(EASL), "EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease", Obes. Facts, 9, pp.65~90 (2016)
7. 강성희, "KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 27(3), pp.363~401 (2021), 대한간학회
8. Leung, C., "The role of the gut microbiota in NAFLD", Nat. Rev. Gastroenterol. Hepatol, 13, pp.412~425 (2016)
9. Suez, J., "The pros, cons, and many unknowns of probiotics", Nat. Med, 25, pp.716~729 (2019)
10. Cohen, L. J., "Commensal bacteria make GPCR ligands that mimic human signalling molecules", Nature, 549, pp.48~53 (2017)
11. Marra, F., "Lipotoxicity and the gut-liver axis in NASH pathogenesis", J. Hepatol, 68, pp.280~295 (2018)
12. Parada Venegas, D., "Short chain fatty acids(SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases", Front. Immunol, 10, pp.277~ (2019)
13. Qiu, L., "Lactobacillus plantarum ZDY04 exhibits a strain-specific property of lowering TMAO via the modulation of gut microbiota in mice", Food Funct, 9, pp.4299~4309 (2018)
14. Barnett, A. M., "Metabolism of caprine milk carbohydrates by probiotic bacteria and Caco-2: HT29–MTX epithelial co-cultures and their impact on intestinal barrier integrity", Nutrients, 10, pp.949~ (2018)
15. Behera, S. S., "Lactobacillus plantarum with functional properties : an approach to increase safety and shelf-life of fermented foods", Biomed. Res. Int, 2018, pp.9361614~ (2018)
16. Zhao, Z., "Lactobacillus plantarum NA136 improves the non-alcoholic fatty liver disease by modulating the AMPK", Nrf2 pathway, 2019, pp.103, 5843~5850
17. Na Young Lee, "Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis", Clinical and Molecular Hepatology, 27(1), pp.110~124 (2021), 대한간학회[DOI]
18. Love, M. I., "Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2", Genome Biol, 15, pp.1~21 (2014)
19. Wieland, A., "Systematic review : microbial dysbiosis and nonalcoholic fatty liver disease", Aliment. Pharmacol. Ther, 42, pp.1051~1063 (2015)
20. Lattouf, R., "Picrosirius red staining : a useful tool to appraise collagen networks in normal and pathological tissues", J. Histochem. Cytochem, 62, pp.751~758 (2014)
21. Ayala, J. E., "Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice", Dis. Model. Mech, 3, pp.525~534 (2010)
22. Cheung, O., "Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression", Hepatology, 48, pp.1810~1820 (2008)
23. Betrapally, N. S., "Changes in the intestinal microbiome and alcoholic and nonalcoholic liver diseases: causes or effects?", Gastroenterology, 150, pp.1745~1755 (2016)
24. Zhu, L., "Characterization of gut microbiomes in nonalcoholic steatohepatitis(NASH)patients : a connection between endogenous alcohol and NASH", Hepatology, 57, pp.601~609 (2013)
25. Jones, R. M., "Lactobacilli modulate epithelial cytoprotection through the Nrf2 pathway", Cell Rep, 12, pp.1217~1225 (2015)
26. Harte, A. L., "Elevated endotoxin levels in non-alcoholic fatty liver disease", J. Inflamm, 7, pp.1~10 (2010)
27. Zhang, D., "Milk fat globule membrane ameliorates necrotizing enterocolitis in neonatal rats and suppresses lipopolysaccharide-induced inflammatory response in IEC-6 enterocytes", JPEN J. Parenter. Enter. Nutr, 43, pp.863~873 (2019)
28. Friedman, S. L., "Mechanisms of NAFLD development and therapeutic strategies", Nat. Med, 24, pp.908~922 (2018)
29. Corbin, K. D., "Choline metabolism provides novel insights into non-alcoholic fatty liver disease and its progression", Curr. Opin. Gastroenterol, 28, pp.159~ (2012)
30. Zhao, Z., "Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation", Appl. Microbiol. Biotechnol, 104, pp.5273~5282 (2020)
31. Park, E. -J., "Beneficial effects of Lactobacillus plantarum strains on non-alcoholic fatty liver disease in high fat", high fructose diet-fed rats, 2020, pp.12, 542~
32. Gogoi, M., "Dual role of arginine metabolism in establishing pathogenesis", Curr. Opin. Microbiol, 29, pp.43~48 (2016)
33. Hou, Y., "Nutritionally nonessential amino acids : a misnomer in nutritional sciences", Adv. Nutr, 8, pp.137~139 (2017)
34. Jobgen, W. S., "Regulatory role for the arginine–nitric oxide pathway in metabolism of energy substrates", J. Nutr. Biochem, 17, pp.571~588 (2006)
35. Wu, G., "Arginine metabolism: nitric oxide and beyond", Biochem. J, 336, pp.1~17 (1998)
36. Bringel, F., "Arginine biosynthesis and regulation in Lactobacillus plantarum : the carA gene and the argCJBDF cluster are divergently transcribed", J. Bacteriol, 179, pp.2697~2706 (1997)
37. Nicoloff, H., "Two arginine repressors regulate arginine biosynthesis in Lactobacillus plantarum", J. Bacteriol, 186, pp.6059~6069 (2004)
38. Han, J., "Dietary L-arginine supplementation alleviates immunosuppression induced by cyclophosphamide in weaned pigs", Amino Acids, 37, pp.643~651 (2009)
39. Wu, T., "Arginine relieves the inflammatory response and enhances the casein expression in bovine mammary epithelial cells induced by lipopolysaccharide", Mediat. Inflamm, 2016, pp.9618795~ (2016)
40. Hnia, K., "L-arginine decreases inflammation and modulates the nuclear factor-κB", matrix metalloproteinase cascade in mdx muscle fibers, 2008, pp.172, 1509~1519
41. Lan, J., "L-arginine ameliorates lipopolysaccharide-induced intestinal inflammation through inhibiting the TLR4", NF-κB and MAPK pathways and stimulating β-defensin expression in vivo and in vitro, 2020, pp.68, 2648~2663
42. de Jonge, W. J., "Arginine deficiency affects early B cell maturation and lymphoid organ development in transgenic mice", J. Clin. Invest, 110, pp.1539~1548 (2002)
43. Li, P., "Amino acids and immune function", Br. J. Nutr, 98, pp.237~252 (2007)
44. Giovanardi, R. O., "Pharmacological preconditioning using intraportal infusion of L-arginine protects against hepatic ischemia reperfusion injury", J. Surg. Res, 155, pp.244~253 (2009)
45. Muriel, P., "Liver damage induced by acute cholestasis in the rat is ameliorated partially by L-arginine", Comp. Biochem. Physiol. Part C : Pharmacol. Toxicol. Endocrinol, 120, pp.421~424 (1998)
46. Meng, Q., "L-arginine attenuates Interleukin-1β(IL-1β)induced Nuclear Factor Kappa-Beta(NF-κB)activation in Caco-2 cells", PLoS ONE, 12, pp.e0174441~ (2017)
47. Visigalli, R., "The stimulation of arginine transport by TNFα in human endothelial cells depends on NF-κB activation", Biochim. Biophy. Acta(BBA)-Biomembr, 1664, pp.45~52 (2004)
48. Liu, Z., "Lactobacillus plantarum 23-1 improves intestinal inflammation and barrier function through the TLR4", NF-κB signaling pathway in obese mice, 2022, pp.13, 5971~5986
49. Wang, J., "Probiotic Lactobacillus plantarum promotes intestinal barrier function by strengthening the epithelium and modulating gut microbiota", Front. Microbiol, 9, pp.1953~ (2018)
50. Wu, G., "Pharmacokinetics and safety of arginine supplementation in animals", J. Nutr, 137, pp.1673S~1680S (2007)
51. Tsukumo, D. M., "Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance", Diabetes, 56, pp.1986~1998 (2007)
52. Miura, K., "Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1β in mice", Gastroenterology, 139, pp.323~334 (2010)
53. Henao-Mejia, J., "Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity", Nature, 482, pp.179~185 (2012)
54. Männistö, V., "Serum lipopolysaccharides predict advanced liver disease in the general population", JHEP Rep, 1, pp.345~352 (2019)

관련 논문AI추천